REAL-WORLD IMPACT OF TRIPLE THERAPY WITH FLUTICASONE FUROATE, UMECLIDINIUM, AND VILANTEROL ON ASTHMA CONTROL AMONG US PATIENTS WITH ASTHMA

被引：2
|
作者：
Bogart, Michael
Germain, Guillaume
Laliberte, Frakois
Mahendran, Malena
Duh, Mei S.
机构：
来源：
CHEST | 2022年 / 162卷 / 04期
关键词：
D O I：
10.1016/j.chest.2022.08.1598
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：1930A / 1931A
页数：2
相关论文
共 50 条
  • [31] Real-World Effectiveness of Fluticasone Furoate/ Umeclidinium/Vilanterol Once-Daily Single-Inhaler Triple Therapy for Symptomatic COPD: The ELLITHE Non-Interventional Trial
    Beeh, Kai -Michael
    Scheithe, Karl
    Schmutzler, Heike
    Krueger, Saskia
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2024, 19 : 205 - 216
  • [32] ARE PATIENTS WITH COPD MORE ADHERENT TO FLUTICASONE FUROATE/UMECLIDINIUM/VILANTEROL (FF/UMEC/VI) COMPARED WITH MULTIPLE-INHALER TRIPLE THERAPY IN A REAL-WORLD UK PRIMARY CARE TREATED POPULATION?
    Halpin, D. M. G.
    Rothnie, K. J.
    Banks, V.
    Czira, A.
    Compton, C.
    Wood, R.
    Tritton, T.
    Massey, O.
    Wild, R.
    Snowise, N.
    Gubba, E.
    Sharma, R.
    Ismaila, A. S.
    Vogelmeier, C. F.
    THORAX, 2021, 76 : A20 - A21
  • [33] Real-life effectiveness of fluticasone furoate/vilanterol after switching from fluticasone/salmeterol or budesonide/formoterol therapy in patients with symptomatic asthma: Relvar Ellipta for Real Asthma Control Study (RERACS study)
    Shimizu, Yasuo
    Shiobara, Taichi
    Arai, Ryo
    Chibana, Kazuyuki
    Takemasa, Akihiro
    JOURNAL OF THORACIC DISEASE, 2020, 12 (05) : 1877 - 1883
  • [34] Fluticasone furoate/vilanterol versus fluticasone propionate in patients with asthma and exercise-induced bronchoconstriction
    Martin, Neil
    Weiler, John M.
    Pearlman, David
    Jacques, Loretta
    Nunn, Carol
    Forth, Richard
    West, Sarah
    Dunn, Karen
    O'Byrne, Paul M.
    JOURNAL OF ASTHMA, 2020, 57 (04) : 431 - 440
  • [35] Population pharmacokinetics of inhaled fluticasone furoate and vilanterol in adult and adolescent patients with asthma
    Allen, Ann
    Siederer, Sarah
    Yang, Shuying
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2016, 54 (04) : 269 - 281
  • [36] Adherence and Persistence with Fluticasone Furoate/Umeclidinium/Vilanterol and Budesonide/Glycopyrrolate/Formoterol Fumarate Among Patients with Chronic Obstructive Pulmonary Disease: A Real-world United States Study
    Noorduyn, S.
    Young, C.
    Lee, L.
    Germain, G.
    Laliberte, F.
    Lejeune, D.
    Klimek, J.
    Dirocco, K.
    Paczkowski, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [37] Triple Therapy of Fluticasone Furoate, Umeclidinium, Vilanterol- A Compelling Choice in Severe Chronic Obstructive Pulmonary Disease
    Nathan, B. Jagan
    Sahay, Melina, I
    Gautham, A. K.
    Sriram, D. K.
    George, Melvin
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2021, 15 (02) : CP7 - CP7
  • [38] Real-Life Clinical and Functional Effects of Fluticasone Furoate/Umeclidinium/Vilanterol-Combined Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease
    Pelaia, Corrado
    Procopio, Giada
    Deodato, Maria Rosaria
    Florio, Olivia
    Maglio, Angelantonio
    Sciacqua, Angela
    Vatrella, Alessandro
    Pelaia, Girolamo
    RESPIRATION, 2021, 100 (02) : 127 - 134
  • [39] Effectiveness of fluticasone furoate/vilanterol versus fluticasone propionate/salmeterol on asthma control in the Salford Lung Study
    Jacques, Loretta
    Bakerly, Nawar Diar
    New, John P.
    Svedsater, Henrik
    Lay-Flurrie, James
    Leather, David A.
    JOURNAL OF ASTHMA, 2019, 56 (07) : 748 - 757
  • [40] Pharmacokinetics of fluticasone furoate, umeclidinium, and vilanterol as a triple therapy in healthy volunteers (vol 53, pg 753, 2015)
    Brealey, Noushin
    Gupta, Ashutosh
    Renaux, Jessica
    Mehta, Rashmi
    Allen, Ann
    Henderson, Alex
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2016, 54 (01) : 76 - 80
12345